Significados de bladder tumor em inglês

Hematuria during surgery led to the discovery of a solid bladder tumor.

Simultaneous transurethral bladder tumor and prostate resection was performed at surgeon discretion.

The results show a wide range of CEA antigen content in exofoliated bladder tumor cells.

The course of these "anticipatory positive" cases and the time to bladder tumor recurrence remains unknown.

The time to conversion to a positive FISH result or the development of a bladder tumor was recorded.

The changes of all three cluster VFs were found to be associated with bladder tumor response to chemotherapy.

Two and a half years after the initial therapy, urinary bladder tumor diagnosed transitional cell carcinoma histologically was found.

Background: Transurethral resection of bladder tumor (TURBT) is the standard approach to bladder tumors but suffers from several disadvantages.

This review summarizes the current understanding of the role of DNA repair pathway alterations in bladder tumor biology and response to therapy.

The prognosis after a diagnosis of both bladder and prostate cancer seems to depend mainly on the prognosis of the bladder tumor.

Transitional cell carcinoma (TCC) is the most common bladder tumor and approximately 90% of bladder TCC are superficial at initial diagnosis.

Retrospective analysis of the bladder tumor patients was performed to reveal the clinical results of partial cystectomy or transurethral resection (TUR).

Objective: In this project, a bladder registration and navigation system was developed to improve bladder tumor documentation and consequently increase reproducibility of the cystoscopy.

Materials and methods: With the predetermined number of three clusters, k-means clustering was performed on nondimensionalized Amp and kep estimates of each bladder tumor.

These results clearly indicate that although BITC may have weak carcinogenic potency, it is a potent chemopreventive agent against bladder tumor induction by BBN.

Forty six patients with non muscle invasive bladder cancer who underwent transurethral resection of bladder tumor and completed two years follow up were included.